# Novo Nordisk invests DKK 8.5B in new production facility in Odense, Denmark

Novo Nordisk announced plans to invest 8.5 billion Danish kroner to establish a new finished production facility and warehouse in Odense, Denmark. The site will cover over 40,000 m² and produce medicines for rare diseases like haemophilia. Construction has commenced and is scheduled to be completed in 2027, creating 400 permanent jobs.

- Type: New facility
- Announced: 2024-12-16
- Where: Odense, Denmark, Denmark
- Value: $1.20B (8.50B DKK)
- Jobs: 400
- Starts operating: 2027
- Status: under construction
- Capacity: over 40,000 m²
- Products: medicines for rare diseases, haemophilia treatments
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Novo Nordisk](https://endata.com/companies/17868.md)

## Sources

- [globenewswire.com](https://www.globenewswire.com/news-release/2024/12/16/2997222/0/en/novo-nordisk-invests-dkk-8-5-billion-in-new-production-facility-in-odense-denmark.html), 2024-12-16: "The investment marks the first time in this century that Novo Nordisk breaks ground in Denmark by establishing a new production site."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.